Literature DB >> 30691711

Immunomodulators and Biologics: Beyond Stepped-Care Therapy.

Mauli Desai1, John Oppenheimer2, David M Lang3.   

Abstract

This review highlights recent data concerning efficacy and safety of biological agents that are currently approved by Food and Drug Administration (FDA), as well as several agents that will likely soon be FDA approved, for management of properly selected patients with severe persistent asthma that is poorly or not well controlled despite "stepped care" management according to best evidence.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Benralizumab; Dupilumab; Mepolizumab; Omalizumab; Reslizumab

Mesh：

Substances：

Year:  2019        PMID： 30691711     DOI： 10.1016/j.ccm.2018.10.011

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  2 in total

1.  Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic.

Authors:  Luciana Kase Tanno; Pascal Demoly; Bryan Martin; Jonathan Berstein; Mario Morais-Almeida; Michael Levin; Alessandro Fiocchi; Mario Sánchez-Borges; Luis R Caraballo; Gary Wong; José Antonio Ortega-Martell; Philip Rouadi; Anahí Yáñez; Liang Lu Wang; David B Peden; Manana Chikhladze; Sandra N González-Díaz; Jean-François Fontaine; James Sublett; Yoon-Seok Chang; Giovanni Passalacqua; Ignacio J Ansotegui; Motohiro Ebisawa; Gianenrico Senna; Marco Caminati
Journal:  World Allergy Organ J       Date:  2021-01-31       Impact factor: 4.084

Review 2.  COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.

Authors:  Marcus S Shaker; John Oppenheimer; Mitchell Grayson; David Stukus; Nicholas Hartog; Elena W Y Hsieh; Nicholas Rider; Cullen M Dutmer; Timothy K Vander Leek; Harold Kim; Edmond S Chan; Doug Mack; Anne K Ellis; David Lang; Jay Lieberman; David Fleischer; David B K Golden; Dana Wallace; Jay Portnoy; Giselle Mosnaim; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.